Lombard Odier Asset Management (USA) Corp
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1491719
New York, NY
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$305,192
-$114,261 QoQ
Shares Held
395
-47.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Sep 30, 2020CallValue
$3,638,570
CallShares
6,500
PutValue
$3,638,570
PutShares
6,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lombard Odier Asset Management (USA) Corp holds $499,500 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANAB |
Anaptysbio, Inc
|
7,400 | $499,500 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $305,192 | 395 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $419,453 | 746 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $311,850 | 594 | Shares | Other | 2025-08-14 | |
| 2020-09-30 | $3,638,570 | 6,500 | Call | Other | 2020-11-16 | |
| 2020-09-30 | $3,638,570 | 6,500 | Put | Other | 2020-11-16 | |
| 2020-09-30 | $1,347,950 | 2,408 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $4,053,725 | 6,500 | Put | Other | 2020-08-14 | |
| 2020-06-30 | $4,053,725 | 6,500 | Call | Other | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||